Clinical Trial Update: Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)

View source ↗

Summary

This clinical trial update describes the planned study on adherence to Growth Hormone Therapy with Norditropin and its impact on near-final height in children w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Born Small For Gestational Age
• Growth Hormone Deficiency in Children

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Deficiency in Children, Born Small for Gestational Age | Status: ENROLLING_BY_INVITATION